Aspen Pharmacare Holdings Ltd Financials

Market Capitalization R54.28 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	12.12
Forward PE	5.79
Price to Sales TTM	R1.19
Price to Book MRQ	R63.78
Enterprise to Revenue	1.80
Enterprise to EBITDA	7.57

Financial Reports as of Jun. 30, 2024

Financials

Fiscal Year Ends	2024-06-30
Most Recent Quarter	2024-06-30
Profit Margin	9.84%
Operating Margin	17.74%
Return on Assets TTM	4.21%
Return on Equity TTM	5.25%

Income Statement

Revenue TTM	R44,706,000,000
Revenue per Share TTM	R102.51
Quarterly Revenue Growth	3.90%
Gross Profit TTM	R19,454,000,000
EBITDA	R11,834,000,000
Net Income to Common TTM	R4,404,000,000
Diluted EPS TTM	R10.08
Quarterly Earnings Growth YoY	3.20%

Balance Sheet

Total Cash MRQ	R11,766,000,000
Total Cash per Share MRQ	R15.32
Total Debt MRQ	R
Total Debt to Equity MRQ	41.69
Current Ratio MRQ	2.35
Book Value per Share MRQ	R191.59

Cash Flow

Operating Cash Flow TTM	R5,464,000,000
Levered Free Cash Flow TTM	R4,404,000,000

APN Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	444,238,254
Float Shares	370,867,910
Avg 10 Volume	1,264,201
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	19.38%
% Held by Institutions	70.04%

Stock Price Summary

Beta	0.43
Fifty Two Week Low	R10575.00
Fifty Two Week High	R27713.00
Fifty Two Week Change	-94.86%
Day 50 MA	R12120.22
Day 200 MA	R16074.44

Dividends and Splits

Forward Annual Dividend Rate	R3.59
Forward Annual Dividend Yield	3.00%
Trailing Annual Dividend Rate	R3.59
Trailing Annual Dividend Yield	0.03%
Payout Ratio	35.60%
Dividend Date
Ex Dividend Date	2024-09-18
Last Split Factor
Last Split Date	2016-04-19